ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

Countries step up to supply oxygen and medicine to India

'Vaccine diplomacy' arrives in South Asia with not-so-ulterior motives

A shipment of oxygen concentrators, ventilators and other medical supplies arrive from Russia on April 29. (Indian External Affairs Ministry via AP)

NEW DELHI -- The international community is scrambling to provide assistance to India, which is being ravaged by new coronavirus variants. But in leapfrogging one another to announce shipments of oxygen, medical supplies and other emergency aid, the U.S., European nations and dozens of other countries appear to be making certain diplomatic calculations.

India, which occupies a key position in terms of Indo-Pacific security, is in dire need of oxygen and drugs, Foreign Secretary Harsh Vardhan Shringla said Thursday during a news conference.

Shringla also said the country has received offers of support from over 40 nations.

On Saturday, India for the first time counted more than 400,000 new daily cases, up from the just over 15,000 new daily cases that were being reported at the beginning of March, when infection totals began a steep ascent.

India, which now leads the world in new cases, also counted more than 3,500 deaths on Saturday.

As the totals climb, hospitals are running out of beds and oxygen, and the medical system is verging on collapse.

The U.S. said it will provide $100 million worth of medical products to India. The products include 1,100 oxygen cylinders, 20,000 doses of the antiviral drug remdesivir and raw materials from which 20 million doses of coronavirus vaccine can be produced.

From Europe, Germany has expressed an intention to supply artificial respirators and medical masks, France plans to provide liquid oxygen and the U.K. intends to offer oxygen concentrators, according to Indian news outlets.

Japan on Friday began procedures to supply India with artificial respirators and oxygen concentrators, which inhale air and exhale oxygen.

While India runs out of oxygen to treat coronavirus patients, its vaccine stores are also dangerously low -- despite the fact that the country boasts the world's largest capacity to produce vaccines.

Production, however, cannot keep up with soaring demand from frightened citizens rushing to be inoculated.

The Indian government planned to start vaccinating people above the age of 18 on Saturday, but cities are already short on doses.

Medical workers tend to a COVID-19 patient inside the ICU ward at Holy Family Hospital in New Delhi on April 29.   © Reuters

Offers of aid from some countries appear to be tinged with diplomatic motives.

On Wednesday, Indian Prime Minister Narendra Modi and Russian President Vladimir Putin held an emergency phone call to discuss COVID-19 countermeasures.

India in mid-April approved the use of the Russian-made Sputnik V vaccine. During the phone call, Modi and Putin confirmed that India will soon start producing Sputnik V. They also agreed to establish a 2+2 ministerial dialogue between foreign and defense ministers.

By deepening cooperative relations with India, Russia appears to be positioning itself as a wedge between India and its Quad partners -- the U.S., Japan and Australia.

Quad is shorthand for the Quadrilateral Security Dialogue.

China is also upping its diplomatic game in South Asia. Wang Yi, China's state councilor and foreign minister, on Tuesday held a video conference with his counterparts from Afghanistan, Pakistan, Nepal, Sri Lanka and Bangladesh, ostensibly to discuss coronavirus countermeasures. China had invited India to the meeting, but India's foreign minister did not log on.

During the conference, Wang reportedly offered to provide the South Asian nations with vaccine supplies and post-pandemic economic assistance, and he said China will push ahead with the Belt and Road Initiative, its massive cross-border infrastructure drive. He added that China will cooperate with India as the need arises.

According to the Chinese Foreign Ministry, China has exported around 26,000 ventilators and oxygen concentrators to India. The two countries are embroiled in a long-standing border dispute that flared into hostilities last June, and India remains wary of China's "vaccine diplomacy." But there is no doubt that prompt assistance is important to New Delhi.

In mid-March, the four Quad leaders outlined a plan to supply the world with about 1 billion vaccine doses by the end of 2022, utilizing India's abundant production capacity. Soon thereafter, however, coronavirus variants began their tear across India, making it all but impossible for India to export vaccine supplies. India's predicament means the Quad will likely have to make new plans to come up with those 1 billion doses.

In contrast to China's active support, Japan has decided to provide only 600 ventilators and oxygen concentrators to India. it is difficult for Japan to match China and Russia in terms of scale and speed, as it is trying to deal with the spread of infection at home and working to expand the capacity of its medical system. The Quad, for its part, will be asked to provide effective support in order to demonstrate its solidarity.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more